Canada’s Decision To Make Public More Clinical Trial Data Puts Pressure On FDA

The U.S. Food and Drug Administration treats most data it gets on the development of new drugs and medical devices as confidential to companies. Critics say making the data public would help patients.(Image credit: Teerapat Seedafong/EyeEm/Getty Images)

From http://besthealthnews.com/2019/10/canadas-decision-to-make-public-more-clinical-trial-data-puts-pressure-on-fda/?utm_source=rss&utm_medium=rss&utm_campaign=canadas-decision-to-make-public-more-clinical-trial-data-puts-pressure-on-fda

from
https://healthnews010.wordpress.com/2019/10/12/canadas-decision-to-make-public-more-clinical-trial-data-puts-pressure-on-fda/

From https://aubreyflores.blogspot.com/2019/10/canadas-decision-to-make-public-more.html

from
https://aubreyflores.wordpress.com/2019/10/12/canadas-decision-to-make-public-more-clinical-trial-data-puts-pressure-on-fda/

From https://christinowlin.blogspot.com/2019/10/canadas-decision-to-make-public-more.html

from
https://christinowlin.wordpress.com/2019/10/12/canadas-decision-to-make-public-more-clinical-trial-data-puts-pressure-on-fda/